T

Tune Therapeutics

75 employees

Tune Therapeutics is an epigenetic programming platform for the treatment of disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
cell therapy
gene therapy
epigenetics

Date founded

2020

Funding rounds raised

Total raised

$40M

from 3 investors over 3 rounds

T

Tune Therapeutics raised $40M on December 2, 2021

Investors: Mission BioCapital, Emerson Collective and Saisei Ventures

FAQ